Sito Bio: The listing application for the chemical raw material drug Methylprednisolone has been approved
I'm PortAI, I can summarize articles.
Sito Bio's holding subsidiary, Shandong Sray Pharmaceutical Co., Ltd., recently received approval from the National Medical Products Administration for the marketing application of methylprednisolone chemical raw materials. Methylprednisolone is a medium-acting, halogen-free corticosteroid medication suitable for emergency treatment and management of various diseases, including endocrine disorders, rheumatic diseases, and skin diseases
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Zhitong The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments